Cargando…

Hepatic and small bowel mucormycosis after chemotherapy in a patient with acute lymphocytic leukemia.

Mucormycosis is a rare but invasive opportunistic fungal infection with increased frequency during chemotherapy-induced neutropenia. The clinical infections due to Mucor include rhinocerebral, pulmonary, cutaneous, gastrointestinal and disseminated diseases. The first two are the most common disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Suh, I. W., Park, C. S., Lee, M. S., Lee, J. H., Chang, M. S., Woo, J. H., Lee, I. C., Ryu, J. S.
Formato: Texto
Lenguaje:English
Publicado: Korean Academy of Medical Sciences 2000
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3054635/
https://www.ncbi.nlm.nih.gov/pubmed/10895981
_version_ 1782199993561513984
author Suh, I. W.
Park, C. S.
Lee, M. S.
Lee, J. H.
Chang, M. S.
Woo, J. H.
Lee, I. C.
Ryu, J. S.
author_facet Suh, I. W.
Park, C. S.
Lee, M. S.
Lee, J. H.
Chang, M. S.
Woo, J. H.
Lee, I. C.
Ryu, J. S.
author_sort Suh, I. W.
collection PubMed
description Mucormycosis is a rare but invasive opportunistic fungal infection with increased frequency during chemotherapy-induced neutropenia. The clinical infections due to Mucor include rhinocerebral, pulmonary, cutaneous, gastrointestinal and disseminated diseases. The first two are the most common diseases and all entities are associated with a high mortality rate. Still hepatic involvement of Mucor is rarely reported. We experienced a case of hepatic and small bowel mucormycosis in a 56-year-old woman after induction chemotherapy for B-cell acute lymphocytic leukemia. Initial symptoms were a high fever unresponsive to broad spectrum antibiotics and pain in the left lower abdominal quadrant. It was followed by septic shock, deterioration of icterus and progressively elevated transaminase. An abdominal CT demonstrated multiple hypodense lesions with distinct margins in both lobes of liver and pericolic infiltration at small bowel and ascending colon. Diagnosis was confirmed by biopsy of the liver. The histopathology of the liver showed hyphae with the right-angle branching, typical of mucormycosis. The patient was managed with amphotericin B and operative correction of the perforated part of the small bowel was performed. However, the patient expired due to progressive hepatic failure despite corrective surgery and long-term amphotericin B therapy.
format Text
id pubmed-3054635
institution National Center for Biotechnology Information
language English
publishDate 2000
publisher Korean Academy of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-30546352011-03-15 Hepatic and small bowel mucormycosis after chemotherapy in a patient with acute lymphocytic leukemia. Suh, I. W. Park, C. S. Lee, M. S. Lee, J. H. Chang, M. S. Woo, J. H. Lee, I. C. Ryu, J. S. J Korean Med Sci Research Article Mucormycosis is a rare but invasive opportunistic fungal infection with increased frequency during chemotherapy-induced neutropenia. The clinical infections due to Mucor include rhinocerebral, pulmonary, cutaneous, gastrointestinal and disseminated diseases. The first two are the most common diseases and all entities are associated with a high mortality rate. Still hepatic involvement of Mucor is rarely reported. We experienced a case of hepatic and small bowel mucormycosis in a 56-year-old woman after induction chemotherapy for B-cell acute lymphocytic leukemia. Initial symptoms were a high fever unresponsive to broad spectrum antibiotics and pain in the left lower abdominal quadrant. It was followed by septic shock, deterioration of icterus and progressively elevated transaminase. An abdominal CT demonstrated multiple hypodense lesions with distinct margins in both lobes of liver and pericolic infiltration at small bowel and ascending colon. Diagnosis was confirmed by biopsy of the liver. The histopathology of the liver showed hyphae with the right-angle branching, typical of mucormycosis. The patient was managed with amphotericin B and operative correction of the perforated part of the small bowel was performed. However, the patient expired due to progressive hepatic failure despite corrective surgery and long-term amphotericin B therapy. Korean Academy of Medical Sciences 2000-06 /pmc/articles/PMC3054635/ /pubmed/10895981 Text en
spellingShingle Research Article
Suh, I. W.
Park, C. S.
Lee, M. S.
Lee, J. H.
Chang, M. S.
Woo, J. H.
Lee, I. C.
Ryu, J. S.
Hepatic and small bowel mucormycosis after chemotherapy in a patient with acute lymphocytic leukemia.
title Hepatic and small bowel mucormycosis after chemotherapy in a patient with acute lymphocytic leukemia.
title_full Hepatic and small bowel mucormycosis after chemotherapy in a patient with acute lymphocytic leukemia.
title_fullStr Hepatic and small bowel mucormycosis after chemotherapy in a patient with acute lymphocytic leukemia.
title_full_unstemmed Hepatic and small bowel mucormycosis after chemotherapy in a patient with acute lymphocytic leukemia.
title_short Hepatic and small bowel mucormycosis after chemotherapy in a patient with acute lymphocytic leukemia.
title_sort hepatic and small bowel mucormycosis after chemotherapy in a patient with acute lymphocytic leukemia.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3054635/
https://www.ncbi.nlm.nih.gov/pubmed/10895981
work_keys_str_mv AT suhiw hepaticandsmallbowelmucormycosisafterchemotherapyinapatientwithacutelymphocyticleukemia
AT parkcs hepaticandsmallbowelmucormycosisafterchemotherapyinapatientwithacutelymphocyticleukemia
AT leems hepaticandsmallbowelmucormycosisafterchemotherapyinapatientwithacutelymphocyticleukemia
AT leejh hepaticandsmallbowelmucormycosisafterchemotherapyinapatientwithacutelymphocyticleukemia
AT changms hepaticandsmallbowelmucormycosisafterchemotherapyinapatientwithacutelymphocyticleukemia
AT woojh hepaticandsmallbowelmucormycosisafterchemotherapyinapatientwithacutelymphocyticleukemia
AT leeic hepaticandsmallbowelmucormycosisafterchemotherapyinapatientwithacutelymphocyticleukemia
AT ryujs hepaticandsmallbowelmucormycosisafterchemotherapyinapatientwithacutelymphocyticleukemia